Transverse myelitis historical perspective: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
(8 intermediate revisions by one other user not shown)
Line 5: Line 5:


==Overview==
==Overview==
Transverse myelitis was first discovered by Dr. Suchett-Kaye, an English neurologist at St. Charles Hospital in London, utilized the term “acute transverse myelitis” in 1948. Cases of “acute myelitis” have been described earlier as cases of “acute myelitis” that have been described in association with or after infection and [[smallpox]] vaccination.
==Historical Perspective==
==Historical Perspective==


===Discovery===
===Discovery===
* There is limited information about the historical perspective of [disease name].
OR
*[Disease name] was first discovered by [name of scientist], a [nationality + occupation], in [year]/during/following [event].
*The association between [important risk factor/cause] and [disease name] was made in/during [year/event].
*In [year], [scientist] was the first to discover the association between [risk factor] and the development of [disease name].
*In [year], [gene] mutations were first implicated in the pathogenesis of [disease name].
===Landmark Events in the Development of Treatment Strategies===


===Impact on Cultural History===
*Transverse myelitis was first discovered by Dr. Suchett-Kaye, an English neurologist at St. Charles Hospital in London, utilized the term “acute transverse myelitis” in 1948.<ref name="pmid28798719">{{cite journal| author=Hsam NBO, Angstwurm K, Peters S, Fuchs K, Schuierer G, Bogdahn U | display-authors=etal| title=Fulminant Acute Ascending Hemorrhagic Myelitis Treated with Eculizumab. | journal=Front Neurol | year= 2017 | volume= 8 | issue=  | pages= 345 | pmid=28798719 | doi=10.3389/fneur.2017.00345 | pmc=5529383 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28798719  }} </ref>


===Famous Cases===
*Cases of “acute myelitis” have been described earlier as cases of “acute myelitis” that have been described in association with or after infection and [[smallpox]] vaccination.<ref name="pmid15956176">{{cite journal| author=Krishnan C, Kerr DA| title=Idiopathic transverse myelitis. | journal=Arch Neurol | year= 2005 | volume= 62 | issue= 6 | pages= 1011-3 | pmid=15956176 | doi=10.1001/archneur.62.6.1011 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15956176  }} </ref>
The following are a few famous cases of [disease name]:


==References==
==References==

Latest revision as of 19:49, 7 July 2020

Transverse myelitis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Transverse myelitis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Transverse myelitis historical perspective On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Transverse myelitis historical perspective

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Transverse myelitis historical perspective

CDC on Transverse myelitis historical perspective

Transverse myelitis historical perspective in the news

Blogs on Transverse myelitis historical perspective

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Transverse myelitis historical perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohamadmostafa Jahansouz M.D.[2]

Overview

Transverse myelitis was first discovered by Dr. Suchett-Kaye, an English neurologist at St. Charles Hospital in London, utilized the term “acute transverse myelitis” in 1948. Cases of “acute myelitis” have been described earlier as cases of “acute myelitis” that have been described in association with or after infection and smallpox vaccination.

Historical Perspective

Discovery

  • Transverse myelitis was first discovered by Dr. Suchett-Kaye, an English neurologist at St. Charles Hospital in London, utilized the term “acute transverse myelitis” in 1948.[1]
  • Cases of “acute myelitis” have been described earlier as cases of “acute myelitis” that have been described in association with or after infection and smallpox vaccination.[2]

References

  1. Hsam NBO, Angstwurm K, Peters S, Fuchs K, Schuierer G, Bogdahn U; et al. (2017). "Fulminant Acute Ascending Hemorrhagic Myelitis Treated with Eculizumab". Front Neurol. 8: 345. doi:10.3389/fneur.2017.00345. PMC 5529383. PMID 28798719.
  2. Krishnan C, Kerr DA (2005). "Idiopathic transverse myelitis". Arch Neurol. 62 (6): 1011–3. doi:10.1001/archneur.62.6.1011. PMID 15956176.

Template:WH Template:WS